Technology | Nuclear Imaging | June 09, 2016

Siemens Healthineers Debuts Mobile PET/CT System, Molecular Imaging Software at SNMMI ‘16

Latest version of syngo.via for Molecular Imaging adds SPECT capabilities; Biograph Horizon PET/CT now has mobile configuration

Siemens Healthineers, SNMMI '16, molecular imaging, syngo.via, Biograph Horizon PET/CT, mobile configuration

June 9, 2016 — At the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), Siemens Healthineers will highlight a new release of its syngo.via for Molecular Imaging software. The company will also feature a new mobile configuration of its Biograph Horizon positron emission tomography/computed tomography (PET/CT) system at the meeting, June 11-15 in San Diego.

The new version of the syngo.via for Molecular Imaging software enables preprocessing, reading and reporting for PET and, for the first time, single photon emission computed tomography (SPECT). This enables physicians to use the intuitive user interface to allow for synergies across departments.

The new iteration of syngo.via for Molecular Imaging offers four new features. For SPECT, organ processing for nuclear medicine helps physicians visualize and quantify the physiological characteristics of organs such as the lungs, kidneys and stomach. For PET, the Molecular Tumor Volume (MTV) and Total Lesion Glycolysis (TLG) features together enable physicians to measure the standardized metabolic activity of the entire tumor mass, potentially improving the preoperative identification of high-risk patients and the prognostic value in predicting overall survival. Hybrid gating 4-D visualization of PET and CT supports therapy planning and delivery.

And syngo.via MI Workplace – the company’s cost-effective, scalable configuration of syngo.via for Molecular Imaging – is designed to bolster the performance of PET and SPECT scanners. In addition to image processing, syngo.via MI Workplace may increase diagnostic confidence by quantifying disease parameters in a wide range of clinical areas. Available with the Biograph Horizon PET/CT system and with all Symbia SPECT and SPECT/CT systems, syngo.via MI Workplace may increase a facility’s clinical capabilities and can be expanded to accommodate an ever-evolving exam mix.

Siemens Healthineers also debuts the mobile configuration of its recently introduced Biograph Horizon PET/CT system, which delivers high-end functionality at an attractive total cost of ownership. This new mobile-ready version of Biograph Horizon is intended for cost-conscious healthcare facilities that do not yet possess the patient volume to support installation of a fixed PET/CT. The mobile configuration also may be ideal for consolidated health systems looking to tailor their imaging delivery strategy in diverse service areas.

Migrating technology from the company’s premium Biograph family of PET/CT systems to help providers address more clinical indications in oncology, neurology and cardiology while also introducing new efficiencies and cost savings, Biograph Horizon enables physicians to visualize small lesions early. The system’s 4 mm lutetium orthosilicate (LSO) crystals scintillate faster and boast a higher light output than commonly used bismuth germanate oxide (BGO) crystals, yielding high image resolution and better image quality as well as enabling Time-of-Flight acquisition. By receiving more detailed patient data earlier, clinicians may stage disease and evaluate therapy response more accurately, contributing to more effective care pathways.

With the addition of the mobile version of Biograph Horizon, the entire line of Biograph PET/CT systems from Siemens Healthineers – including Biograph mCT and Biograph mCT Flow – is available in mobile as well as fixed configurations.

For more information: www.healthcare.siemens.com

Related Content

News | Nuclear Imaging

April 13, 2022 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American Society of Nuclear ...

Home April 13, 2022
Home
Videos | Nuclear Imaging

American Society of Nuclear Cardiology (ASNC) President Dennis Calnon, M.D., MASNC, FASE, FSCCT, director of cardiac ...

Home February 01, 2022
Home
Feature | Nuclear Imaging | By Staff of the American Society of Nuclear Cardiology (ASNC)

A year after COVID-19 turned the world upside down, the American Society of Nuclear Cardiology (ASNC) asked members how ...

Home June 02, 2021
Home
News | Nuclear Imaging

April 1, 2021 – The ability to measure myocardial blood flow (MBF) as part of myocardial perfusion imaging (MPI) is one ...

Home April 01, 2021
Home
News | Nuclear Imaging

December 4, 2020 — Spectrum Dynamics Medical, Inc., has received Canadian Medical Device License from Health Canada for ...

Home December 04, 2020
Home
News | Nuclear Imaging

September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine ...

Home October 07, 2020
Home
Feature | Nuclear Imaging | Dave Fornell, Editor

There were a few key takeaways from the American Society of Nuclear Cardiology (ASNC) 2019 annual meeting in September ...

Home November 22, 2019
Home
Videos | Nuclear Imaging

Rob Beanlands, M.D., FASNC, 2019 American Society of Nuclear Cardiology (ASNC) president, shares a couple trends he sees ...

Home November 07, 2019
Home
Videos | Nuclear Imaging

Robert C. Hendel, M.D., explains some of the new cardiac radiotracers in the pipeline that were discussed in sessions at ...

Home November 06, 2019
Home
Feature | Nuclear Imaging | Christopher A. Hanson M.D., and Jamieson M. Bourque M.D., MHS

Cardiac amyloidosis is a highly morbid and underdiagnosed infiltrative cardiomyopathy that is characterized by the ...

Home July 22, 2019
Home
Subscribe Now